1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Slovenia Pharmaceuticals and Healthcare Report Q4 2016

Slovenia Pharmaceuticals and Healthcare Report Q4 2016

  • October 2016
  • -
  • Business Monitor International
  • -
  • 79 pages

Includes 3 FREE quarterly updates

BMI View:

Much like those of its Western European neighbours, Slovenia's health profile is dominated by non-communicable diseases, which pose a great burden and provide opportunities for innovative drugmakers. However, despite an attractive epidemiological profile, the country's small population and market size will somewhat act as a deterrent to any major investment from multinationals.


Headline Expenditure Projections

- Pharmaceuticals: EUR671mn (USD745mn) in 2015 to EUR656mn (USD702mn) in 2016; -2.2% in local currency terms and -5.7% in US dollar terms. Forecasts revised downwards compared to previous quarter.

- Healthcare: EUR3.44bn (USD3.82bn) in 2015 to EUR3.53bn (USD3.78bn) in 2016; 2.7% in local currency terms and -1.0% in US dollar terms. Forecasts unchanged compared to previous quarter.

Table Of Contents

Slovenia Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Slovenia 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Slovenia 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Slovenia 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Slovenia 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Slovenia 2012-2020) 24
OTC Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Slovenia 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Slovenia 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Slovenia 2014-2020) 30
Industry Risk/Reward Index 31
Central And Eastern Europe Risk/Reward Index - Q4 2016 31
Slovenia Risk/Reward Index 38
Rewards 38
Risks 38
Regulatory Review 40
Intellectual Property Issues 41
Pricing Regime 41
Reimbursement Regime 43
Market Overview 45
Healthcare Sector 46
Table: Healthcare Resources (Slovenia 2010-2015) 50
Table: Healthcare Personnel (Slovenia 2010-2015) 50
Table: Healthcare Activity (Slovenia 2010-2015) 51
Research and Development 51
Clinical Trials 51
Epidemiology 52
Slovenia Pharmaceuticals and Healthcare Report Q4 2016$$
Competitive Landscape 55
Research-Based Industry 55
Table: Table: Multinational Market Activity 55
Generic Drugmakers 56
Company Profile 59
Krka 59
Lek (Novartis/Sandoz) 64
Demographic Forecast 68
Table: Population Headline Indicators (Slovenia 1990-2025) 69
Table: Key Population Ratios (Slovenia 1990-2025) 69
Table: Urban/Rural Population and Life Expectancy (Slovenia 1990-2025) 70
Table: Population By Age Group (Slovenia 1990-2025) 70
Table: Population By Age Group % (Slovenia 1990-2025) 71
Glossary 73
Methodology 75
Pharmaceutical Expenditure Forecast Model 75
Healthcare Expenditure Forecast Model 75
Notes On Methodology 76
Risk/Reward Index Methodology 77
Index Overview 78
Table: Pharmaceutical Risk/Reward Index Indicators 78
Indicator Weightings 79

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.